Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Reduction of ectopic bone growth in critically-sized rat mandible defects by delivery of rhBMP-2 from kerateine biomaterials.

Kowalczewski CJ, Tombyln S, Wasnick DC, Hughes MR, Ellenburg MD, Callahan MF, Smith TL, Van Dyke ME, Burnett LR, Saul JM.

Biomaterials. 2014 Mar;35(10):3220-8. doi: 10.1016/j.biomaterials.2013.12.087.

2.

Recombinant human bone morphogenetic protein 2 combined with an osteoconductive bulking agent for mandibular continuity defects in nonhuman primates.

Herford AS, Lu M, Buxton AN, Kim J, Henkin J, Boyne PJ, Caruso JM, Rungcharassaeng K, Hong J.

J Oral Maxillofac Surg. 2012 Mar;70(3):703-16. doi: 10.1016/j.joms.2011.02.088.

PMID:
21549480
3.

Long-term controlled delivery of rhBMP-2 from collagen-hydroxyapatite scaffolds for superior bone tissue regeneration.

Quinlan E, Thompson EM, Matsiko A, O'Brien FJ, López-Noriega A.

J Control Release. 2015 Jun 10;207:112-9. doi: 10.1016/j.jconrel.2015.03.028.

PMID:
25817394
4.

Effect of recombinant human bone morphogenetic protein-4 with carriers in rat calvarial defects.

Ahn SH, Kim CS, Suk HJ, Lee YJ, Choi SH, Chai JK, Kim CK, Han SB, Cho KS.

J Periodontol. 2003 Jun;74(6):787-97.

PMID:
12886988
5.

Effect of recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge with space-providing biomaterials on the augmentation of chronic alveolar ridge defects.

Barboza EP, Caúla AL, Caúla Fde O, de Souza RO, Geolás Neto L, Sorensen RG, Li XJ, Wikesjö UM.

J Periodontol. 2004 May;75(5):702-8.

PMID:
15212353
6.

Bioinspired trimodal macro/micro/nano-porous scaffolds loading rhBMP-2 for complete regeneration of critical size bone defect.

Tang W, Lin D, Yu Y, Niu H, Guo H, Yuan Y, Liu C.

Acta Biomater. 2016 Mar 1;32:309-23. doi: 10.1016/j.actbio.2015.12.006.

PMID:
26689464
7.

Effect of recombinant human bone morphogenetic protein-2, -4, and -7 on bone formation in rat calvarial defects.

Hyun SJ, Han DK, Choi SH, Chai JK, Cho KS, Kim CK, Kim CS.

J Periodontol. 2005 Oct;76(10):1667-74.

PMID:
16253088
8.

Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog.

Barboza EP, Duarte ME, Geolás L, Sorensen RG, Riedel GE, Wikesjö UM.

J Periodontol. 2000 Mar;71(3):488-96.

PMID:
10776939
9.
10.

Characterization of absorbable collagen sponges as rhBMP-2 carriers.

Friess W, Uludag H, Foskett S, Biron R, Sargeant C.

Int J Pharm. 1999 Sep 30;187(1):91-9.

PMID:
10502616
11.

Effect of recombinant human bone morphogenetic protein-2 on bone regeneration in large defects of the growing canine skull after dura mater replacement with a dura mater substitute.

He D, Genecov DG, Herbert M, Barcelo R, Elsalanty ME, Weprin BE, Opperman LA.

J Neurosurg. 2010 Feb;112(2):319-28. doi: 10.3171/2009.1.JNS08976.

PMID:
19267528
12.

Effect of rhBMP-2 dose on bone formation/maturation in a rat critical-size calvarial defect model.

Pelaez M, Susin C, Lee J, Fiorini T, Bisch FC, Dixon DR, McPherson JC 3rd, Buxton AN, Wikesjö UM.

J Clin Periodontol. 2014 Aug;41(8):827-36. doi: 10.1111/jcpe.12270.

PMID:
24807100
13.

The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formation.

Luca L, Rougemont AL, Walpoth BH, Gurny R, Jordan O.

J Control Release. 2010 Oct 1;147(1):38-44. doi: 10.1016/j.jconrel.2010.06.011.

PMID:
20600403
15.

Development of collagen-hydroxyapatite scaffolds incorporating PLGA and alginate microparticles for the controlled delivery of rhBMP-2 for bone tissue engineering.

Quinlan E, López-Noriega A, Thompson E, Kelly HM, Cryan SA, O'Brien FJ.

J Control Release. 2015 Jan 28;198:71-9. doi: 10.1016/j.jconrel.2014.11.021.

PMID:
25481441
16.

Tunable Keratin Hydrogels for Controlled Erosion and Growth Factor Delivery.

Ham TR, Lee RT, Han S, Haque S, Vodovotz Y, Gu J, Burnett LR, Tomblyn S, Saul JM.

Biomacromolecules. 2016 Jan 11;17(1):225-36. doi: 10.1021/acs.biomac.5b01328.

PMID:
26636618
17.

The stimulation of healing within a rat calvarial defect by mPCL-TCP/collagen scaffolds loaded with rhBMP-2.

Sawyer AA, Song SJ, Susanto E, Chuan P, Lam CX, Woodruff MA, Hutmacher DW, Cool SM.

Biomaterials. 2009 May;30(13):2479-88. doi: 10.1016/j.biomaterials.2008.12.055.

PMID:
19162318
18.

Effect of recombinant human bone morphogenetic protein-4 dose on bone formation in a rat calvarial defect model.

Pang EK, Im SU, Kim CS, Choi SH, Chai JK, Kim CK, Han SB, Cho KS.

J Periodontol. 2004 Oct;75(10):1364-70.

PMID:
15562914
19.
20.

Evaluation of a compression resistant matrix for recombinant human bone morphogenetic protein-2.

Lu SX, Fiorini T, Lee J, Prasad HS, Buxton AN, Bisch FC, Dixon DR, Susin C, Wikesjö UM.

J Clin Periodontol. 2013 Jul;40(7):688-97. doi: 10.1111/jcpe.12109.

PMID:
23627347
Items per page

Supplemental Content

Support Center